Acer Therapeutics Inc (NASDAQ:ACER)

Delayed Data
As of 4:00pm ET
 -0.47 / -2.41%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Acer Therapeutics Inc have a median target of 41.50, with a high estimate of 50.00 and a low estimate of 33.00. The median estimate represents a +118.42% increase from the last price of 19.00.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Acer Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.17%
Growthannually 25.78%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.